132 related articles for article (PubMed ID: 23294633)
1. Active glycogen synthase kinase-3 and tau pathology-related tyrosine phosphorylation in pR5 human tau transgenic mice.
Köhler C; Dinekov M; Götz J
Neurobiol Aging; 2013 May; 34(5):1369-79. PubMed ID: 23294633
[TBL] [Abstract][Full Text] [Related]
2. Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice.
Ishizawa T; Sahara N; Ishiguro K; Kersh J; McGowan E; Lewis J; Hutton M; Dickson DW; Yen SH
Am J Pathol; 2003 Sep; 163(3):1057-67. PubMed ID: 12937146
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
4. Distribution of spleen tyrosine kinase and tau phosphorylated at tyrosine 18 in a mouse model of tauopathy and in the human hippocampus.
Köhler C; Fuhr V; Dinekov M
Brain Res; 2017 Dec; 1677():1-13. PubMed ID: 28919467
[TBL] [Abstract][Full Text] [Related]
5. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
6. Terminal hypothermic Tau.P301L mice have increased Tau phosphorylation independently of glycogen synthase kinase 3α/β.
Maurin H; Lechat B; Borghgraef P; Devijver H; Jaworski T; Van Leuven F
Eur J Neurosci; 2014 Jul; 40(2):2442-53. PubMed ID: 24754737
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy.
Köhler C; Bista P; Götz J; Schröder H
Brain Res; 2010 Aug; 1347():111-24. PubMed ID: 20513372
[TBL] [Abstract][Full Text] [Related]
8. GSK3: a possible link between beta amyloid peptide and tau protein.
Hernández F; Gómez de Barreda E; Fuster-Matanzo A; Lucas JJ; Avila J
Exp Neurol; 2010 Jun; 223(2):322-5. PubMed ID: 19782073
[TBL] [Abstract][Full Text] [Related]
9. Divergent phosphorylation pattern of tau in P301L tau transgenic mice.
Deters N; Ittner LM; Götz J
Eur J Neurosci; 2008 Jul; 28(1):137-47. PubMed ID: 18662339
[TBL] [Abstract][Full Text] [Related]
10. Dynamic association of tau with neuronal membranes is regulated by phosphorylation.
Pooler AM; Usardi A; Evans CJ; Philpott KL; Noble W; Hanger DP
Neurobiol Aging; 2012 Feb; 33(2):431.e27-38. PubMed ID: 21388709
[TBL] [Abstract][Full Text] [Related]
11. Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates.
Vega IE; Cui L; Propst JA; Hutton ML; Lee G; Yen SH
Brain Res Mol Brain Res; 2005 Aug; 138(2):135-44. PubMed ID: 15913839
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
[TBL] [Abstract][Full Text] [Related]
13. Dual effects of PKNalpha and protein kinase C on phosphorylation of tau protein by glycogen synthase kinase-3beta.
Isagawa T; Mukai H; Oishi K; Taniguchi T; Hasegawa H; Kawamata T; Tanaka C; Ono Y
Biochem Biophys Res Commun; 2000 Jun; 273(1):209-12. PubMed ID: 10873588
[TBL] [Abstract][Full Text] [Related]
14. Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice.
Terwel D; Muyllaert D; Dewachter I; Borghgraef P; Croes S; Devijver H; Van Leuven F
Am J Pathol; 2008 Mar; 172(3):786-98. PubMed ID: 18258852
[TBL] [Abstract][Full Text] [Related]
15. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
[TBL] [Abstract][Full Text] [Related]
16. A mouse model to study tau pathology related with tau phosphorylation and assembly.
Engel T; Lucas JJ; Hernández F; Avila J
J Neurol Sci; 2007 Jun; 257(1-2):250-4. PubMed ID: 17362999
[TBL] [Abstract][Full Text] [Related]
17. Pattern of tau hyperphosphorylation and neurotransmitter markers in the brainstem of senescent tau filament forming transgenic mice.
Morcinek K; Köhler C; Götz J; Schröder H
Brain Res; 2013 Feb; 1497():73-84. PubMed ID: 23261664
[TBL] [Abstract][Full Text] [Related]
18. Granulovacuolar degeneration and unfolded protein response in mouse models of tauopathy and Aβ amyloidosis.
Köhler C; Dinekov M; Götz J
Neurobiol Dis; 2014 Nov; 71():169-79. PubMed ID: 25073087
[TBL] [Abstract][Full Text] [Related]
19. Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation.
Schindowski K; Belarbi K; Bretteville A; Ando K; Buée L
Genes Brain Behav; 2008 Feb; 7 Suppl 1(1):92-100. PubMed ID: 18184373
[TBL] [Abstract][Full Text] [Related]
20. Tau phosphorylation in hippocampus results in toxic gain-of-function.
Avila J; Gómez de Barreda E; Engel T; Lucas JJ; Hernández F
Biochem Soc Trans; 2010 Aug; 38(4):977-80. PubMed ID: 20658988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
